Chimeric_JJ Influenza_NP A_NP Viruses_NP with_IN a_DT Functional_NP Influenza_NP B_NP Virus_NP Neuraminidase_NP or_CC Hemagglutinin_NP Reassortment_NP of_IN influenza_NN A_NP and_CC B_NP viruses_NNS has_VBZ never_RB been_VBN observed_VBN in_IN vivo_JJ or_CC in_IN vitro_NN ._SENT Using_VBG reverse_JJ genetics_NN techniques_NNS ,_, we_PP generated_VBD recombinant_JJ influenza_NN A/WSN/33_NP (_( WSN_NP )_) viruses_NNS carrying_VBG the_DT neuraminidase_NN (_( NA_NP )_) of_IN influenza_NN B_NN virus_NN ._SENT Chimeric_JJ viruses_NNS expressing_VBG the_DT full-length_JJ influenza_NN B/Yamagata/16/88_NP virus_NN NA_NP grew_VBD to_TO titers_NNS similar_JJ to_TO that_DT of_IN wild-type_NN influenza_NN WSN_NP virus_NN ._SENT Recombinant_JJ viruses_NNS in_IN which_WDT the_DT cytoplasmic_JJ tail_NN or_CC the_DT cytoplasmic_JJ tail_NN and_CC the_DT transmembrane_JJ domain_NN of_IN the_DT type_NN B_NP NA_NP were_VBD replaced_VBN with_IN those_DT of_IN the_DT type_NN A_DT NA_NP were_VBD impaired_VBN in_IN tissue_NN culture_NN ._SENT This_DT finding_VBG correlates_NNS with_IN reduced_VBN NA_NP content_NN in_IN virions_NNS ._SENT We_PP also_RB generated_VBD a_DT recombinant_JJ influenza_NN A_DT virus_NN expressing_VBG a_DT chimeric_JJ hemagglutinin_NN (_( HA_NP )_) protein_NN in_IN which_WDT the_DT ectodomain_NN is_VBZ derived_VBN from_IN type_NN B/Yamagata/16/88_NP virus_NN HA_NP ,_, whereas_IN both_CC the_DT cytoplasmic_JJ and_CC the_DT transmembrane_NN domains_NNS are_VBP derived_VBN from_IN type_NN A/WSN_NP virus_NN HA_NP ._SENT This_DT A/B_NP chimeric_JJ HA_NP virus_NN did_VBD not_RB grow_VB efficiently_RB in_IN MDCK_NP cells_NNS ._SENT However_RB ,_, after_IN serial_JJ passage_NN we_PP obtained_VBD a_DT virus_NN population_NN that_WDT grew_VBD to_TO titers_NNS as_IN high_JJ as_IN wild-type_NN influenza_NN A_DT virus_NN in_IN MDCK_NP cells_NNS ._SENT One_CD amino_NN acid_JJ change_NN in_IN position_NN 545_CD (_( H545Y_NP )_) was_VBD found_VBN to_TO be_VB responsible_JJ for_IN the_DT enhanced_JJ growth_NN characteristics_NNS of_IN the_DT passaged_VBN virus_NN ._SENT Taken_VBN together_RB ,_, we_PP show_VBP here_RB that_IN the_DT absence_NN of_IN reassortment_NN between_IN influenza_NN viruses_NNS belonging_VBG to_TO different_JJ A_NP and_CC B_NP types_NNS is_VBZ not_RB due_JJ to_TO spike_VB glycoprotein_NN incompatibility_NN at_IN the_DT level_NN of_IN the_DT full-length_JJ NA_NP or_CC of_IN the_DT HA_NP ectodomain_NN ._SENT There_EX are_VBP three_CD types_NNS of_IN influenza_NN viruses_NNS :_: A_DT ,_, B_NP ,_, and_CC C._NP Originally_RB ,_, the_DT members_NNS of_IN the_DT influenza_NN A_DT virus_NN type_NN were_VBD defined_VBN by_IN their_PP$ serologic_JJ properties_NNS by_IN using_VBG polyclonal_JJ antisera_NN made_VBN against_IN internal_JJ proteins_NNS of_IN the_DT viruses_NNS ._SENT All_DT members_NNS of_IN type_NN A_DT influenza_NN viruses_NNS cross-react_NN with_IN polyclonal_JJ antibodies_NNS made_VBN from_IN an_DT influenza_NN A_DT virus_NN but_CC not_RB with_IN those_DT made_VBN from_IN an_DT influenza_NN B_NP or_CC C_NP virus_NN ._SENT This_DT classification_NN was_VBD later_RBR confirmed_VBN when_WRB the_DT entire_JJ sequences_NNS of_IN the_DT genomes_NNS of_IN influenza_NN A_NP ,_, B_NP ,_, and_CC C_NP viruses_NNS were_VBD obtained_VBN ._SENT The_DT genes_NNS coding_VBG for_IN the_DT surface_NN glycoproteins_NNS can_MD vary_VB dramatically_RB among_IN different_JJ viruses_NNS belonging_VBG to_TO the_DT same_JJ type_NN ,_, but_CC the_DT genes_NNS coding_VBG for_IN the_DT internal_JJ proteins_NNS are_VBP always_RB more_RBR related_VBN among_IN strains_NNS of_IN one_CD type_NN than_IN those_DT of_IN strains_NNS belonging_VBG to_TO two_CD different_JJ types_NNS ._SENT Thus_RB ,_, type_NN A_NP ,_, type_NN B_NN ,_, and_CC type_NN C_NP influenza_NN viruses_NNS can_MD be_VB reliably_RB classified_VBN ._SENT Sequencing_NP has_VBZ also_RB proven_VBN that_IN influenza_NN type_NN A_NP ,_, B_NP ,_, and_CC C_NP viruses_NNS have_VBP evolved_VBN from_IN a_DT common_JJ ancestor_NN ._SENT One_CD of_IN the_DT hallmarks_NNS of_IN RNA_NP viruses_NNS with_IN segmented_VBN genomes_NNS is_VBZ the_DT ability_NN to_TO undergo_VB reassortment_NN ._SENT Thus_RB ,_, the_DT segmented_VBN negative-strand_NP RNA_NP viruses_NNS readily_RB reshuffle_VBP RNA_NP segments_NNS in_IN progeny_NN viruses_NNS derived_VBN from_IN two_CD parent_NN viruses_NNS infecting_VBG the_DT same_JJ cell_NN ._SENT For_IN example_NN ,_, human_JJ influenza_NN A_DT viruses_NNS have_VBP been_VBN shown_VBN to_TO undergo_VB reassortment_NN of_IN genes_NNS by_IN capturing_VBG RNA_NP segments_NNS from_IN avian_JJ influenza_NN A_DT viruses_NNS ,_, resulting_VBG in_IN novel_JJ human_JJ viruses_NNS with_IN altered_JJ pathogenicity_NN and/or_CC potential_JJ to_TO cause_VB pandemics_NNS ._SENT In_IN contrast_NN ,_, reassortment_NN of_IN genes_NNS between_IN a_DT type_NN A_DT and_CC a_DT type_NN B_NN virus_NN has_VBZ never_RB been_VBN observed_VBN ,_, suggesting_VBG that_IN these_DT viruses_NNS have_VBP become_VBN different_JJ species_NNS ,_, if_IN speciation_NN is_VBZ defined_VBN as_IN having_VBG lost_VBN the_DT ability_NN to_TO mate_VB with_IN another_DT influenza_NN virus_NN ,_, resulting_VBG in_IN an_DT exchange_NN of_IN genetic_JJ information_NN ._SENT The_DT absence_NN of_IN reassortment_NN between_IN influenza_NN viruses_NNS belonging_VBG to_TO different_JJ types_NNS has_VBZ been_VBN puzzling_JJ because_IN it_PP has_VBZ been_VBN shown_VBN that_IN the_DT RNA-dependent_NP RNA_NP polymerase_NN of_IN an_DT influenza_NN A_DT virus_NN can_MD recognize_VB the_DT promoter_NN sequence_NN of_IN an_DT influenza_NN B_NN virus_NN ._SENT Specifically_RB ,_, we_PP have_VBP shown_VBN that_IN an_DT influenza_NN A_DT virus_NN whose_WP$ neuraminidase_NN (_( NA_NP )_) gene_NN is_VBZ flanked_VBN by_IN the_DT 5_CD '_POS and_CC 3_CD '_'' noncoding_NN sequences_NNS of_IN the_DT influenza_NN B_NN virus_NN NS_NP gene_NN is_VBZ viable_JJ ._SENT This_DT virus_NN is_VBZ infectious_JJ --_: -albeit_NN attenuated_JJ --_: -and_NN this_DT is_VBZ proof_JJ that_IN the_DT absence_NN of_IN reassortment_NN between_IN influenza_NN viruses_NNS of_IN different_JJ types_NNS is_VBZ not_RB due_JJ to_TO the_DT divergence_NN of_IN promoters_NNS ,_, since_IN the_DT heterologous_JJ influenza_NN A_DT virus_NN RNA-dependent_NP RNA_NP polymerase_NN appears_VBZ to_TO recognize_VB the_DT promoter_NN of_IN the_DT influenza_NN B_NN virus_NN NS_NP gene_NN ._SENT In_IN vitro_NN experiments_NNS with_IN minigenomes_NNS of_IN type_NN A_DT and_CC type_NN B_NN influenza_NN viruses_NNS have_VBP confirmed_VBN this_DT finding_NN ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP show_VBP that_IN recombinant_JJ influenza_NN A_DT viruses_NNS whose_WP$ full-length_JJ NA_NP or_CC HA_NP ectodomain_NN is_VBZ derived_VBN from_IN an_DT influenza_NN B_NN virus_NN are_VBP viable_JJ ._SENT This_DT finding_NN suggests_VBZ that_IN the_DT "_`` mixing_VBG "_'' of_IN influenza_NN A_NP and_CC B_NP virus_NN proteins_NNS is_VBZ compatible_JJ with_IN the_DT rescue_NN of_IN infectious_JJ virus_NN and_CC that_IN the_DT NA_NP or_CC HA_NP of_IN an_DT influenza_NN A_DT virus_NN can_MD be_VB functionally_RB replaced_VBN with_IN the_DT corresponding_JJ protein_NN from_IN an_DT influenza_NN B_NN virus_NN ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Madin-Darby_NP canine_JJ kidney_NN (_( MDCK_NP )_) and_CC 293T_JJ cells_NNS were_VBD maintained_VBN in_IN Dulbecco_NP modified_JJ Eagle_NP medium_NN (_( DMEM_NP )_) with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN and_CC antibiotics_NNS ._SENT Influenza_NN A/WSN/33_NP (_( H1N1_NP )_) (_( WSN_NP )_) ,_, B/Yamagata/16/88_NP (_( Yamagata_NP )_) ,_, and_CC recombinant_JJ viruses_NNS WSN-BNA_NP ,_, WSN-BNA/A65_NP ,_, WSN-BNA/ACT_NP ,_, WSN-BNA/ACT-ATM_NP ,_, and_CC WSN-BHA/ACT-ATM_NP were_VBD propagated_VBN in_IN MDCK_NP cells_NNS in_IN DMEM_NP containing_VBG 0.3_CD %_NN bovine_JJ serum_NN albumin_NN ._SENT Virus_NN titers_NNS were_VBD measured_VBN by_IN plaque_NN assay_NN on_IN MDCK_NP cells_NNS ._SENT Parental_JJ B/Yamagata_NP virus_NN ,_, as_RB well_RB as_IN all_DT recombinant_JJ viruses_NNS ,_, containing_VBG the_DT NA_NP of_IN the_DT influenza_NN B_NN virus_NN were_VBD grown_VBN and_CC plaqued_VBN in_IN the_DT presence_NN of_IN 1_CD mug_NN of_IN TPCK_NP (_( l-1-tosylamide-2-phenylmethyl_NN chloromethyl_NN ketone)-treated_JJ trypsin_NN (_( Sigma_NP Co.)/ml_NP ._SENT For_IN preparation_NN of_IN virus_NN stocks_NNS used_VBN to_TO analyze_VB proteins_NNS by_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) ,_, viruses_NNS were_VBD propagated_VBN in_IN 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS for_IN 3_CD days_NNS at_IN 37C_JJ ._SENT Viruses_NNS were_VBD purified_VBN from_IN allantoic_JJ fluid_NN by_IN spinning_VBG the_DT supernatant_JJ at_IN 10,000_CD rpm_NN for_IN 30_CD min_NN and_CC by_IN ultracentrifugation_NN through_IN a_DT 30_CD %_NN sucrose_NN cushion_NN ._SENT For_IN enzyme-linked_JJ immunosorbent_JJ assays_NNS (_( ELISAs_NP )_) ,_, viruses_NNS were_VBD amplified_VBN in_IN MDCK_NP cells_NNS for_IN 48_CD h_NN (_( WSN_NP ,_, WSN-BNA_NP ,_, and_CC WSN-BNA/A65_NP )_) or_CC 72_CD h_NN (_( WSN-BNA/ACT_NP and_CC WSN-BNA/ACT-ATM_NP )_) at_IN 37C_JJ or_CC for_IN 72_CD h_NN at_IN 35C_JJ (_( Yamagata_NP )_) and_CC purified_VBN from_IN cell_NN culture_NN supernatant_JJ by_IN using_VBG the_DT same_JJ protocol_NN ._SENT Construction_NN of_IN plasmids_NNS ._SENT |_SYM All_NP of_IN the_DT plasmid_NP constructs_NNS described_VBD here_RB were_VBD cloned_VBN by_IN using_VBG the_DT same_JJ strategy_NN ,_, i.e._FW ,_, by_IN insertion_NN of_IN a_DT PCR_NP product_NN into_IN the_DT SapI_NP sites_NNS of_IN the_DT plasmid_NP pPolI-SapI-Rb_NN ._SENT This_DT strategy_NN positions_VBZ the_DT PCR_NP product_NN between_IN a_DT truncated_JJ human_JJ RNA_NP polymerase_NN I_NP promoter_NN and_CC a_DT hepatitis_NP delta_NN virus_NN ribozyme_NN sequence_NN in_IN such_PDT a_DT way_NN that_IN a_DT negative_JJ (_( vRNA_NN sense_NN )_) transcript_NN is_VBZ produced_VBN from_IN the_DT polymerase_NN I_PP promoter_NN ._SENT The_DT sequence_NN of_IN all_DT PCR_NP inserts_NNS was_VBD confirmed_VBN ,_, and_CC nucleotide_NN changes_NNS that_WDT had_VBD been_VBN introduced_VBN by_IN PCR_NP were_VBD corrected_VBN by_IN using_VBG QuikChange_NP XL_NP site-directed_JJ mutagenesis_NN (_( Stratagene_NP ,_, La_NP Jolla_NP ,_, Calif._NP )_) when_WRB appropriate_JJ ._SENT The_DT cloning_VBG of_IN influenza_NN A/WSN_NP virus_NN NA_NP and_CC hemagglutinin_NN (_( HA_NP )_) genes_NNS into_IN the_DT pPolI_JJ transcription_NN plasmid_NN has_VBZ been_VBN described_VBN previously_RB ._SENT The_DT HA_NP and_CC NA_NP genes_NNS of_IN B/Yamagata/16/88_NP were_VBD amplified_VBN by_IN reverse_JJ transcription-PCR_NN (_( RT-PCR_NP )_) and_CC cloned_VBN into_IN pPolI-SapI-Rb_NN to_TO create_VB the_DT plasmids_NNS pPolI-HA-Yamagata_NNS and_CC pPolI-NA-Yamagata_NNS ,_, respectively_RB ._SENT All_DT NA_NP genes_NNS and_CC the_DT HA_NP genes_NNS described_VBD here_RB were_VBD generated_VBN by_IN PCR_NP amplification_NN of_IN the_DT appropriate_JJ gene_NN fragments_NNS from_IN pPolI-NA-WSN_NN ,_, pPolI-HA-WSN_NNS ,_, pPolI-NA-Yamagata_NNS ,_, and_CC pPolI-HA-Yamagata_NNS ,_, followed_VBN by_IN ligation_NN into_IN pPolI-SapI-Rb_NN ._SENT All_DT primers_NNS covering_VBG the_DT 3_CD '_POS and_CC 5_CD '_'' noncoding_JJ regions_NNS (_( NCRs_NN )_) of_IN WSN_NP NA_NP or_CC WSN_NP HA_NP contain_VBP the_DT SapI_NP sites_NNS that_WDT are_VBP used_VBN for_IN inserting_VBG the_DT NA_NP or_CC the_DT HA_NP constructs_NNS into_IN pPolI-SapI-Rb_NN ._SENT pPolI-BNA_NP contains_VBZ the_DT Yamagata_NP NA_NP open_JJ reading_NN frame_NN (_( ORF_NP ;_: 466_CD amino_NN acids_NNS [_SYM aa_NN ]_SYM )_) flanked_VBD by_IN the_DT 3_CD '_POS (_( 19-nucleotide_NN [_SYM nt_NNS ]_SYM )_) and_CC 5_CD '_'' (_( 31-nt_JJ )_) vRNA_NN NCRs_NN of_IN the_DT WSN_NP NA_NP vRNA_NP ._SENT pPolI-BNA/A65_NN contains_VBZ the_DT Yamagata_NP NA_NP ORF_NP flanked_VBD by_IN the_DT 3_CD '_POS and_CC 5_CD '_'' ends_NNS of_IN the_DT WSN_NP NA_NP vRNA_NP ._SENT In_IN addition_NN ,_, the_DT 3_CD '_POS NCR_NP is_VBZ extended_VBN by_IN insertion_NN of_IN additional_JJ 65_CD nt_NNS between_IN the_DT 3_CD '_POS NCR_NP and_CC the_DT start_NN codon_NN of_IN the_DT NA_NP ._SENT This_DT 65-nt_JJ sequence_NN corresponds_VBZ to_TO the_DT amino-terminal_JJ codons_NNS of_IN the_DT WSN_NP NA_NP ORF_NP (_( nt_NN 20_CD to_TO 84_CD of_IN the_DT WSN_NP NA_NP segment_NN )_) ._SENT The_DT AUG_NP codons_NNS present_JJ in_IN these_DT 65_CD nt_NNS were_VBD mutated_VBN to_TO UUG_NP ._SENT In_IN addition_NN to_TO the_DT 3_CD '_POS and_CC 5_CD '_'' NCRs_NN ,_, the_DT pPolI-BNA/ACT_NN also_RB contains_VBZ the_DT cytoplasmic_JJ domain_NN (_( six_CD amino-terminal_JJ amino_NN acids_NNS )_) of_IN the_DT influenza_NN A/WSN_NP virus_NN NA_NP ,_, whereas_IN the_DT transmembrane_NN domain_NN (_( 29_CD aa_NN )_) and_CC the_DT ectodomain_NN (_( 425_CD aa_NN )_) are_VBP derived_VBN from_IN the_DT B_NP virus_NN NA_NP ._SENT In_IN pPolI-BNA/ACT-ATM_NN ,_, the_DT cytoplasmic_JJ tail_NN (_( 12_CD aa_NN )_) and_CC the_DT transmembrane_NN domain_NN (_( 29_CD aa_NN )_) of_IN the_DT influenza_NN B_NN virus_NN NA_NP were_VBD replaced_VBN by_IN the_DT corresponding_JJ WSN_NP NA_NP domains_NNS (_( aa_NN 1_CD to_TO 35_CD )_) ._SENT In_IN addition_NN ,_, the_DT 5_CD '_POS NCR_NP is_VBZ extended_VBN by_IN insertion_NN of_IN 36_CD nt_NNS between_IN the_DT stop_NN codon_NN and_CC the_DT 5_CD '_POS NCR_NP ._SENT This_DT 36-nt_JJ sequence_NN corresponds_VBZ to_TO nt_NN 1346_CD to_TO 1381_CD of_IN WSN_NP NA_NP (_( coding_VBG for_IN the_DT 11_CD carboxy-terminal_JJ amino_NN acids_NNS of_IN WSN_NP NA_NP followed_VBD by_IN the_DT stop_NN codon_NN )_) ._SENT pPolI-BHA/ACT-ATM_NN contains_VBZ the_DT 3_CD '_'' (_( 32_CD nt_NNS )_) and_CC 5_CD '_'' (_( 48_CD nt_NNS )_) NCRs_JJ ,_, cytoplasmic_JJ tail_NN (_( 10_CD aa_NN )_) ,_, and_CC transmembrane_NN domain_NN (_( 28_CD aa_NN )_) of_IN the_DT A/WSN_NP HA_NP and_CC the_DT ectodomain_NN (_( 545_CD aa_NN )_) from_IN the_DT B/Yamagata_NP HA_NP ._SENT In_IN pPolI-BHA_NN (_( 583_CD aa_NN )_) the_DT entire_JJ ORF_NP of_IN the_DT B/Yamagata_NP HA_NP is_VBZ flanked_VBN by_IN the_DT A/WSN_NP HA_NP NCRs_NP ._SENT Generation_NN of_IN recombinant_JJ viruses_NNS ._SENT |_SYM For_IN the_DT plasmid-only_JJ rescue_NN of_IN recombinant_JJ WSN_NP viruses_NNS containing_VBG the_DT NA_NP or_CC the_DT HA_NP of_IN influenza_NN B/Yamagata_NP virus_NN ,_, we_PP used_VBD a_DT published_VBN protocol_NN ._SENT Briefly_RB ,_, a_DT coculture_NN of_IN MDCK_NP and_CC 293T_JJ cells_NNS was_VBD transfected_VBN with_IN four_CD expression_NN plasmids_NNS coding_VBG for_IN the_DT PB1_NP ,_, PB2_NP ,_, and_CC PA_NP proteins_NNS ,_, and_CC nucleoprotein_NN (_( NP_NP )_) of_IN WSN_NP and_CC seven_CD pPolI_NN transcription_NN plasmids_NNS ,_, each_DT coding_VBG for_IN one_CD of_IN the_DT WSN_NP virus_NN vRNA_NN segments_NNS ,_, omitting_VBG either_CC the_DT NA_NP or_CC the_DT HA_NP plasmid_NP ._SENT The_DT eighth_JJ segment_NN was_VBD provided_VBN in_IN the_DT form_NN of_IN one_CD of_IN the_DT constructed_VBN pPolI_NN plasmids_NNS encoding_VBG all_DT or_CC part_NN of_IN the_DT influenza_NN B_NN virus_NN NA_NP protein_NN (_( BNA_NP ,_, BNA/A65_NP ,_, BNA/ACT_NP ,_, or_CC BNA/ACT-ATM_NP )_) or_CC the_DT pPolI_JJ plasmid_NN encoding_VBG BHA/ACT-ATM_NP ._SENT A_DT total_NN of_IN 0.5_CD to_TO 1_CD mug_NN of_IN each_DT plasmid_NN was_VBD transfected_VBN by_IN using_VBG Lipofectamine_NP 2000_CD (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) ._SENT At_IN 12_CD h_NN posttransfection_NN the_DT medium_NN was_VBD replaced_VBN by_IN DMEM_NP containing_VBG 0.3_CD %_NN bovine_JJ serum_NN albumin_NN ,_, 10_CD mM_NP HEPES_NP ,_, and_CC 1_CD mug_NN of_IN TPCK-rreated_JJ trypsin/ml_NN ._SENT At_IN 3_CD to_TO 5_CD days_NNS posttransfection_NN ,_, virus-containing_JJ supernatant_JJ was_VBD inoculated_VBN into_IN 7-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ._SENT Eggs_NNS of_IN this_DT young_JJ age_NN were_VBD chosen_VBN because_IN ,_, due_JJ to_TO their_PP$ immunological_JJ immaturity_NN ,_, they_PP induce_VBP low_JJ levels_NNS of_IN interferon_NN after_IN infection_NN ._SENT Allantoic_JJ fluid_NN was_VBD harvested_VBN after_IN 3_CD days_NNS of_IN incubation_NN at_IN 37C_JJ and_CC assayed_VBN for_IN the_DT presence_NN of_IN virus_NN by_IN hemagglutination_NN of_IN chicken_NN red_JJ blood_NN cells_NNS or_CC by_IN plaque_NN formation_NN in_IN MDCK_NP cells_NNS ._SENT The_DT NA_NP or_CC the_DT HA_NP segment_NN of_IN the_DT recovered_VBN mutant_JJ viruses_NNS were_VBD analyzed_VBN by_IN RT-PCR_NP and_CC sequencing_NP ._SENT Briefly_RB ,_, RNA_NP was_VBD extracted_VBN from_IN virus-containing_JJ allantoic_JJ fluid_NN and_CC from_IN cell_NN culture_NN supernatant_JJ by_IN using_VBG the_DT RNeasy_NP Mini_NP kit_NN (_( Qiagen_NP ,_, Inc._NP )_) ._SENT The_DT RNA_NP was_VBD reverse_RB transcribed_VBN with_IN Superscript_NP II_NP RNase_NP H-_NP (_( Invitrogen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT The_DT PCR_NP was_VBD performed_VBN by_IN using_VBG a_DT universal_JJ 3_CD '_POS NCR_NP primer_NN and_CC an_DT NA-_NP or_CC HA-specific_NP 5_CD '_POS NCR_NP primer_NN ._SENT In_IN order_NN to_TO confirm_VB the_DT presence_NN of_IN the_DT recombinant_JJ HA_NP or_CC NAs_NP in_IN the_DT recombinant_JJ viruses_NNS ,_, RT-PCR_NP products_NNS were_VBD subcloned_VBN into_IN pGEM-T_NP (_( Promega_NP Co._NP )_) ,_, identified_VBN by_IN digestion_NN with_IN appropriate_JJ restriction_NN enzymes_NNS ,_, and_CC sequenced_JJ ._SENT Indirect_JJ immunofluorescence_NN analysis_NN ._SENT |_SYM Confluent_JJ monolayers_NNS of_IN MDCK_JJ cells_NNS in_IN 35-mm_JJ dishes_NNS were_VBD infected_VBN with_IN recombinant_JJ viruses_NNS at_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 2_CD ._SENT At_IN 12_CD h_NN postinfection_NN ,_, cells_NNS were_VBD fixed_VBN and_CC permeabilized_VBN by_IN treatment_NN with_IN methanol_NN (_( -20C_NN )_) for_IN 5_CD min_NN ,_, followed_VBN by_IN ethanol_NN (_( -20C_NN )_) for_IN 30_CD s._NN After_IN blocking_VBG with_IN 3_CD %_NN bovine_JJ serum_NN albumin_NN in_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) ,_, cells_NNS were_VBD incubated_VBN for_IN 40_CD min_NN with_IN a_DT monoclonal_NN antibody_NN directed_VBN against_IN NA_NP (_( 9A6_NN )_) or_CC HA_NP (_( 15B6_NP )_) (_( kindly_RB provided_VBN by_IN the_DT Mount_NP Sinai_NP Hybridoma_NP shared_VBD research_NN facility_NN )_) of_IN influenza_NN B/Panama/45/90_NP virus_NN and_CC a_DT polyclonal_JJ serum_NN raised_VBN against_IN WSN_NP virus_NN (_( 8236_CD )_) ._SENT After_IN three_CD washes_VBZ with_IN PBS_NP containing_VBG 0.5_CD %_NN Triton_NP X-100_NP ,_, cells_NNS were_VBD incubated_VBN for_IN 1_CD h_NN with_IN Texas_NP red-conjugated_JJ anti-mouse_NN immunoglobulin_NN G_NP (_( IgG_NP ;_: Rockland_NP )_) and_CC with_IN fluorescein_NN isothiocyanate-labeled_JJ rabbit_NN immunoglobulins_NNS (_( Dako_NP A/S_NP ,_, Copenhagen_NP ,_, Denmark_NP )_) ._SENT After_IN three_CD additional_JJ washes_VBZ ,_, infected_JJ cells_NNS were_VBD analyzed_VBN by_IN fluorescence_NN microscopy_NN ._SENT Growth_NN curve_NN of_IN recombinant_JJ viruses_NNS ._SENT |_SYM MDCK_NP cells_NNS (_( 106_CD )_) in_IN 35-mm_JJ dishes_NNS were_VBD infected_VBN with_IN recombinant_JJ viruses_NNS (_( WSN-BNA_NP ,_, WSN-BNA/A65_NP ,_, WSN-BNA/ACT_NP ,_, WSN-BNA/ACT-ATM_NP ,_, WSN-BHA/ACT-ATM_NP ,_, and_CC rescued_VBD WSN_NP [_SYM rWSN_NN ]_SYM )_) at_IN an_DT MOI_NP of_IN 0.001_CD ._SENT Samples_NNS of_IN supernatants_NNS were_VBD collected_VBN at_IN different_JJ time_NN points_NNS postinfection_NN and_CC plaqued_VBN on_IN MDCK_NP cells_NNS ._SENT PNGase_NP F_NP digestion_NN and_CC SDS-PAGE_NP ._SENT |_SYM Carbohydrate_NN residues_NNS were_VBD removed_VBN from_IN glycoproteins_NNS (_( HA_NP and_CC NA_NP )_) of_IN wild-type_NN and_CC recombinant_JJ viruses_NNS by_IN treating_VBG ca_MD ._SENT 20_CD mug_NN of_IN sucrose-purified_NN virions_NNS with_IN PNGase_NP F_NP (_( New_NP England_NP Biolabs_NP ,_, Inc._NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT Proteins_NNS were_VBD analyzed_VBN by_IN SDS-12_NP %_NN PAGE_NN and_CC staining_VBG with_IN Coomassie_NP brilliant_JJ blue_NN ._SENT ELISA_NP ._SENT |_SYM Dynex_NP Immulon_NP 4HBX_NP flat-bottom_NN microtiter_NN plates_NNS (_( Thermo_NP Labsystems_NP USA_NP ,_, Beverly_NP ,_, Mass._NP )_) were_VBD coated_VBN with_IN serial_JJ twofold_JJ dilutions_NNS in_IN PBS_NP of_IN wild-type_NN influenza_NN A/WSN_NP and_CC B/Yamagata_NP viruses_NNS ;_: with_IN recombinant_JJ WSN-BNA_NP ,_, WSN-BNA/A65_NP ,_, WSN-BNA/ACT_NP ,_, and_CC WSN-BNA/ACT-ATM_NP viruses_NNS ;_: or_CC with_IN PBS_NP only_RB ._SENT All_DT viruses_NNS were_VBD amplified_VBN in_IN MDCK_NP cells_NNS and_CC purified_VBN from_IN cell_NN culture_NN supernatant_JJ as_IN described_VBN above_IN ._SENT Coating_NN was_VBD performed_VBN in_IN duplicates_NNS at_IN room_NN temperature_NN for_IN 15_CD h_NN ,_, starting_VBG with_IN 0.25_CD mug_NN (_( 50_CD mul_NN of_IN a_DT 5-mug/ml_JJ solution_NN )_) of_IN virus_NN ._SENT Plates_NNS were_VBD then_RB blocked_VBN with_IN PBS_NP buffer_NN containing_VBG 1_CD %_NN bovine_JJ serum_NN albumin_NN at_IN room_NN temperature_NN for_IN 90_CD min_NN ._SENT Coated_VBN and_CC blocked_VBN ELISA_NP plates_NNS were_VBD incubated_VBN with_IN 5_CD mug_NN of_IN a_DT monoclonal_NN antibody_NN recognizing_VBG influenza_NN B/Yamagata_NP NA_NP (9A6)/ml_NN at_IN room_NN temperature_NN for_IN 1_CD h._NN The_DT plates_NNS were_VBD washed_VBN four_CD times_NNS with_IN PBS_NP and_CC then_RB incubated_VBN with_IN a_DT 1:2,000_CD dilution_NN of_IN the_DT secondary_JJ antibody_NN (_( anti-mouse_NP IgG-horseradish_NP peroxidase_NN [_SYM Roche_NP Diagnostics_NP Co._NP ,_, Indianapolis_NP ,_, Ind._NP ]_SYM )_) at_IN room_NN temperature_NN for_IN 1_CD h._NP Plates_NP were_VBD washed_VBN again_RB four_CD times_NNS with_IN PBS_NP ,_, and_CC the_DT color_NN was_VBD developed_VBN with_IN ABTS_NP [_SYM 2,2'azinobis(3-ethylbenzthiazolinesulfonic_JJ acid_NN )_) ]_SYM (_( Roche_NP )_) ._SENT The_DT optical_JJ density_NN was_VBD read_VBN at_IN 405_CD nm_NN ,_, and_CC the_DT average_NN of_IN duplicate_JJ samples_NNS was_VBD calculated_VBN after_IN subtraction_NN of_IN the_DT value_NN (_( averaged_VBN )_) obtained_VBD from_IN PBS-coated_JJ wells_NNS ._SENT Generation_NN of_IN influenza_NN A_DT viruses_NNS with_IN chimeric_JJ NA_NP or_CC chimeric_JJ HA_NP segments_NNS derived_VBN from_IN an_DT influenza_NN B_NN virus_NN ._SENT |_SYM Four_CD viruses_NNS possessing_VBG chimeric_JJ influenza_NN B_NN virus_NN NA_NP segments_NNS were_VBD generated_VBN in_IN a_DT background_NN of_IN seven_CD WSN_NP virus_NN segments_NNS ._SENT The_DT structures_NNS of_IN the_DT parental_JJ influenza_NN A_NP (_( WSN_NP )_) and_CC B_NP (_( Yamagata_NP )_) virus_NN segments_NNS ,_, as_RB well_RB as_IN of_IN the_DT chimeric_JJ NA_NP constructs_NNS ,_, are_VBP depicted_VBN in_IN Fig._NN ._SENT For_IN all_DT constructs_NNS ,_, the_DT noncoding_JJ sequences_NNS were_VBD derived_VBN from_IN the_DT A/WSN_NP strain_NN to_TO promote_VB efficient_JJ replication_NN by_IN the_DT WSN_NP polymerase_NN ._SENT For_IN the_DT BNA_NP construct_NN ,_, the_DT entire_JJ coding_VBG region_NN was_VBD derived_VBN from_IN the_DT B_NP virus_NN NA_NP ._SENT The_DT ORF_NP of_IN the_DT NB_NP that_WDT starts_VBZ upstream_RB of_IN that_DT of_IN the_DT B_NP virus_NN NA_NP was_VBD eliminated_VBN ._SENT The_DT BNA/A65_NP construct_NN possesses_VBZ coding_VBG regions_NNS of_IN the_DT entire_JJ influenza_NN B_NN virus_NN NA_NP ORF_NP ._SENT However_RB ,_, this_DT construct_NN contains_VBZ additional_JJ 65_CD nt_NNS derived_VBN from_IN the_DT 5_CD '_POS end_NN of_IN the_DT A/WSN_NP NA_NP ORF_NP (_( with_IN the_DT AUG_NP codons_NNS present_JJ in_IN this_DT sequence_NN changed_VBD to_TO UUG_NP )_) ._SENT This_DT sequence_NN was_VBD included_VBN because_IN sequences_NNS from_IN within_IN the_DT coding_VBG regions_NNS of_IN influenza_NN virus_NN RNA_NP segments_NNS have_VBP been_VBN found_VBN to_TO influence_VB levels_NNS of_IN viral_JJ RNA_NP synthesis_NN and_CC packaging_NN ._SENT Two_CD additional_JJ constructs_NNS were_VBD generated_VBN to_TO assess_VB whether_IN replacement_NN of_IN the_DT transmembrane_NN and/or_CC cytoplasmic_JJ domain_NN in_IN the_DT influenza_NN B_NN virus_NN NA_NP with_IN those_DT of_IN the_DT influenza_NN A_DT virus_NN NA_NP would_MD alter_VB the_DT phenotype_NN of_IN the_DT virus_NN ._SENT In_IN one_CD chimera_NN ,_, BNA/ACT_NP ,_, only_RB the_DT cytoplasmic_JJ tail_NN was_VBD derived_VBN from_IN the_DT A/WSN_NP NA_NP ._SENT In_IN the_DT other_JJ chimeric_JJ NA_NP construct_NN ,_, BNA/ACT-ATM_NP ,_, the_DT transmembrane_NN and_CC cytoplasmic_JJ domains_NNS of_IN the_DT influenza_NN B_NN virus_NN NA_NP segment_NN were_VBD replaced_VBN by_IN those_DT of_IN A/WSN_NP NA_NP ._SENT Similar_JJ to_TO the_DT insertion_NN in_IN BNA/A65_NP ,_, a_DT 36-nt_JJ sequence_NN derived_VBN from_IN the_DT carboxy-terminal_JJ portion_NN of_IN the_DT WSN_NP NA_NP ORF_NP was_VBD included_VBN in_IN the_DT 5_CD '_POS NCR_NP of_IN BNA/ACT-ATM_NP ._SENT We_PP also_RB constructed_VBD a_DT virus_NN expressing_VBG a_DT chimeric_JJ HA_NP segment_NN that_WDT contains_VBZ the_DT carboxy-terminal_JJ cytoplasmic_JJ and_CC transmembrane_JJ domains_NNS of_IN A/WSN_NP HA_NP (_( with_IN the_DT entire_JJ ectodomain_NN deriving_VBG from_IN the_DT influenza_NN B_NN virus_NN HA_NP )_) ._SENT However_RB ,_, WSN_NP viruses_NNS containing_VBG the_DT entire_JJ influenza_NN B/Yamagata_NP virus_NN HA_NP segment_NN flanked_VBN by_IN the_DT NCRs_NN of_IN the_DT WSN_NP virus_NN HA_NP (_( Fig._NN B_NN )_) could_MD not_RB be_VB rescued_VBN ._SENT All_DT recombinant_JJ viruses_NNS were_VBD generated_VBN by_IN using_VBG previously_RB published_VBN protocols_NNS ._SENT The_DT resulting_VBG viruses_NNS were_VBD plaque_NN purified_VBN ,_, amplified_VBN on_IN MDCK_NP cells_NNS and_CC the_DT chimeric_JJ segments_NNS were_VBD analyzed_VBN by_IN RT-PCR_NP and_CC sequenced_JJ ._SENT By_IN these_DT methods_NNS ,_, each_DT of_IN the_DT viruses_NNS was_VBD found_VBN to_TO have_VB the_DT expected_VBN recombinant_JJ gene_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT identity_NN of_IN the_DT chimeric_JJ viruses_NNS was_VBD further_RBR demonstrated_VBN by_IN indirect_JJ immunofluorescence_NN ._SENT MDCK_NP cells_NNS were_VBD infected_VBN with_IN wild-type_NP A/WSN_NP ,_, wild-type_NP B/Yamagata_NP ,_, WSN-BNA_NP ,_, WSN-BNA/A65_NP ,_, WSN-BNA/ACT_NP ,_, and_CC WSN-BNA/ACT-ATM_NP viruses_NNS and_CC WSN-BHA/ACT-ATM_NN virus_NN ._SENT Virus-infected_JJ cells_NNS were_VBD stained_VBN with_IN both_CC an_DT antiserum_NN raised_VBN against_IN WSN_NP virus_NN and_CC either_RB an_DT influenza_NN B_NN virus_NN NA-specific_JJ antibody_NN or_CC an_DT influenza_NN B_NN virus_NN HA-specific_JJ antibody_NN ._SENT All_DT infected_JJ cells_NNS showed_VBD presence_NN of_IN the_DT heterologous_JJ glycoprotein_NN as_RB well_RB as_IN the_DT WSN_NP components_NNS of_IN recombinant_JJ viruses_NNS ._SENT Growth_NN characteristics_NNS of_IN recombinant_JJ viruses_NNS ._SENT |_SYM The_DT multicycle_NN growth_NN of_IN the_DT chimeric_JJ viruses_NNS at_IN 37C_JJ was_VBD compared_VBN in_IN MDCK_NP cells_NNS ._SENT rWSN_NN was_VBD included_VBN for_IN comparison_NN of_IN the_DT growth_NN kinetics_NN of_IN the_DT recombinant_JJ viruses_NNS ._SENT rWSN_NN virus_NN had_VBD been_VBN rescued_VBN by_IN using_VBG the_DT same_JJ WSN_NP "_`` background_NN "_'' plasmids_NNS as_IN those_DT employed_VBN for_IN the_DT recombinant_JJ viruses_NNS analyzed_VBD here_RB ._SENT Thus_RB ,_, these_DT viruses_NNS are_VBP isogenic_JJ differing_VBG only_RB in_IN one_CD gene_NN ._SENT The_DT viruses_NNS possessing_VBG the_DT full-length_JJ influenza_NN B_NN virus_NN NA_NP proteins_NNS ,_, BNA_NP and_CC BNA/A65_NP ,_, grew_VBD to_TO titers_NNS similar_JJ to_TO that_DT of_IN the_DT rWSN_NN virus_NN ._SENT However_RB ,_, WSN-BNA/ACT_NP and_CC WSN-BNA/ACT-ATM_NP viruses_NNS which_WDT express_VBP chimeric_JJ proteins_NNS possessing_VBG portions_NNS of_IN the_DT WSN_NP NA_NP protein_NN displayed_VBD impaired_JJ growth_NN compared_VBN to_TO the_DT rWSN_NN virus_NN ._SENT This_DT experiment_NN was_VBD repeated_VBN with_IN similar_JJ results_NNS ._SENT In_IN contrast_NN to_TO recombinant_JJ WSN_NP viruses_NNS expressing_VBG influenza_NN B_NN virus_NN NAs_NP ,_, the_DT WSN_NP virus_NN expressing_VBG the_DT B_NP virus_NN HA_NP (_( WSN-BHA/ACT-ATM_NP )_) produced_VBD an_DT HA_NP titer_NN of_IN <=8_NN compared_VBN to_TO an_DT HA_NP titer_NN of_IN 256_CD for_IN wild-type_JJ A/WSN_NP virus_NN and_CC did_VBD not_RB form_VB plaques_NNS in_IN MDCK_NP cells_NNS ._SENT In_IN order_NN to_TO increase_VB the_DT growth_NN properties_NNS of_IN this_DT recombinant_JJ virus_NN ,_, it_PP was_VBD serially_RB passaged_VBN in_IN MDCK_NP cells_NNS ._SENT Virus_NN obtained_VBD from_IN the_DT sixth_JJ passage_NN showed_VBD a_DT titer_NN of_IN 108_CD PFU/ml_NN and_CC produced_VBD visible_JJ plaques_NNS in_IN MDCK_NP cells_NNS ._SENT This_DT WSN-BHA/ACT-ATM_NP (_( P6_NP )_) virus_NN was_VBD used_VBN for_IN further_JJR analysis_NN ._SENT The_DT growth_NN dynamics_NNS were_VBD determined_VBN in_IN MDCK_NP cells_NNS and_CC compared_VBN to_TO those_DT of_IN rWSN_NN ._SENT Remarkably_RB ,_, this_DT virus_NN grows_VBZ to_TO titers_NNS comparable_JJ to_TO that_DT of_IN wild-type_JJ A/WSN_NP virus_NN ,_, if_IN not_RB to_TO higher_JJR titers_NNS ._SENT In_IN order_NN to_TO clarify_VB whether_IN adaptive_JJ amino_NN acid_NN changes_NNS had_VBD occurred_VBN in_IN the_DT genes_NNS coding_VBG for_IN BHA/ACT-ATM_NP or_CC for_IN WSN_NP NA_NP that_WDT could_MD account_VB for_IN the_DT markedly_RB increased_VBN growth_NN characteristics_NNS of_IN P6_NP ,_, we_PP cloned_VBD both_DT genes_NNS by_IN RT-PCR_NP ._SENT Four_CD independent_JJ PCR_NP products_NNS of_IN each_DT full-length_JJ HA_NP ,_, as_RB well_RB as_IN of_IN NA_NP ,_, were_VBD sequenced_JJ ._SENT Two_CD of_IN the_DT four_CD RT-PCR_NP products_NNS of_IN the_DT A/WSN_NP NA_NP had_VBD one_CD mutation_NN each_DT (_( L95R_NP and_CC E366G_NP )_) ,_, but_CC there_EX is_VBZ no_DT evidence_NN that_IN any_DT of_IN these_DT mutations_NNS has_VBZ biological_JJ significance_NN ._SENT Interestingly_RB ,_, in_IN all_DT four_CD RT-PCR_NP products_NNS of_IN BHA/ACT-ATM_NP the_DT same_JJ amino_NN acid_NN change_NN was_VBD found_VBN ._SENT This_DT mutation_NN replaces_VBZ histidine_NN at_IN position_NN 545_CD with_IN tyrosine_NN (_( H545Y_NP )_) ._SENT aa_NN 545_CD is_VBZ the_DT carboxy-terminal_JJ amino_NN acid_NN of_IN the_DT influenza_NN B_NP HA_NP ectodomain_NN ,_, immediately_RB followed_VBN by_IN the_DT transmembrane_NN region_NN ._SENT Analysis_NN of_IN HA_NP sequences_NNS available_JJ in_IN the_DT database_NN (_( Influenza_NP Sequence_NP Database_NP ,_, Los_NP Alamos_NP National_NP Laboratory_NP )_) revealed_VBD that_IN all_DT influenza_NN B_NN virus_NN HAs_NNS contain_VBP a_DT histidine_NN at_IN this_DT position_NN ,_, whereas_IN in_IN all_DT influenza_NN A_DT virus_NN H1_NP HAs_NP the_DT last_JJ amino_NN acid_NN of_IN the_DT ectodomain_NN is_VBZ a_DT tyrosine_NN ._SENT In_IN order_NN to_TO investigate_VB whether_IN the_DT improved_VBN growth_NN characteristics_NNS of_IN WSN-BHA/ACT-ATM_NP virus_NN of_IN the_DT sixth_JJ passage_NN compared_VBN to_TO the_DT originally_RB rescued_VBN virus_NN was_VBD a_DT result_NN of_IN the_DT single_JJ amino_NN acid_NN change_NN H545Y_NP in_IN BHA/ACT-ATM_NP ,_, we_PP introduced_VBD this_DT mutation_NN into_IN pPolI-BHA/ACT-ATM_NN by_IN site-directed_JJ mutagenesis_NN ,_, thus_RB creating_VBG pPolI-BHA/ACT-ATM_NN (_( H545Y_NP )_) ._SENT This_DT plasmid_NN was_VBD used_VBN for_IN the_DT rescue_NN of_IN WSN-BHA/ACT-ATM_NP (_( H545Y_NP )_) virus_NN ._SENT Recombinant_JJ WSN-BHA/ACT-ATM_NP (_( H545Y_NP )_) virus_NN was_VBD plaque_NN purified_VBN and_CC amplified_VBN on_IN MDCK_NP cells_NNS ,_, and_CC the_DT presence_NN of_IN the_DT mutated_VBN nucleotide_NN sequence_NN in_IN the_DT chimeric_JJ HA_NP segment_NN of_IN this_DT recombinant_JJ virus_NN was_VBD confirmed_VBN by_IN RT-PCR_NP and_CC sequencing_NP of_IN the_DT RT-PCR_NP product_NN (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT recombinant_JJ WSN_NP virus_NN containing_VBG the_DT mutated_VBN HA_NP chimera_NN (_( WSN-BHA/ACT-ATM_NP [_SYM H545Y_NP ]_SYM )_) was_VBD found_VBN to_TO grow_VB to_TO the_DT same_JJ titers_NNS as_IN the_DT passaged_VBN WSN-BHA/ACT-ATM_NP (_( P6_NP )_) virus_NN ,_, suggesting_VBG that_IN the_DT tyrosine_NN at_IN the_DT boundary_NN of_IN ectodomain_NN and_CC transmembrane_NN domain_NN of_IN the_DT HA_NP protein_NN may_MD be_VB responsible_JJ for_IN the_DT improved_VBN growth_NN characteristics_NNS ._SENT Incorporation_NN of_IN the_DT BHA/ACT-ATM_NP protein_NN into_IN virions_NNS ._SENT |_SYM We_PP wanted_VBD to_TO investigate_VB whether_IN the_DT extent_NN of_IN incorporation_NN of_IN the_DT chimeric_JJ HA_NP protein_NN into_IN virions_NNS differed_VBD from_IN that_IN of_IN wild-type_NN influenza_NN A_DT virus_NN HA_NP ._SENT To_TO this_DT end_NN ,_, we_PP amplified_VBD WSN_NP and_CC WSN-BHA/ACT-ATM_NP (_( P6_NP )_) viruses_NNS in_IN 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS and_CC partially_RB purified_VBD viruses_NNS from_IN the_DT allantoic_JJ fluid_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT To_TO obtain_VB a_DT better_JJR resolution_NN of_IN the_DT bands_NNS corresponding_JJ to_TO NP_NP ,_, HA1_NP ,_, and_CC NA_NP ,_, virions_NNS were_VBD treated_VBN with_IN PNGase_NP F_NP to_TO remove_VB N-linked_JJ carbohydrate_NN residues_NNS from_IN the_DT polypeptides_NNS ._SENT The_DT proteins_NNS of_IN both_DT treated_VBN and_CC untreated_JJ virions_NNS were_VBD separated_VBN by_IN SDS-12_NP %_NN PAGE_NN and_CC then_RB visualized_VBN by_IN staining_VBG with_IN Coomassie_NP brilliant_JJ blue_NN ._SENT As_IN expected_VBN ,_, the_DT HA1_JJ subunit_NN of_IN the_DT chimeric_JJ protein_NN ,_, which_WDT is_VBZ 19_CD aa_NN longer_JJR than_IN the_DT WSN_NP HA1_NP ,_, runs_VBZ slower_JJR in_IN the_DT gel_NN ._SENT The_DT incorporation_NN of_IN BHA/ACT-ATM_NP into_IN recombinant_JJ virions_NNS is_VBZ comparable_JJ to_TO that_DT of_IN wild-type_NN influenza_NN A_DT virus_NN HA_NP based_VBN on_IN the_DT amount_NN of_IN NP_NP and_CC M1_JJ present_NN in_IN the_DT preparations_NNS ._SENT Levels_NNS of_IN influenza_NN B_NP NA_NP proteins_NNS in_IN chimeric_JJ viruses_NNS ._SENT |_SYM In_IN order_NN to_TO determine_VB the_DT relative_JJ amounts_NNS of_IN the_DT NA_NP proteins_NNS in_IN the_DT rescued_VBN viruses_NNS ,_, we_PP performed_VBD ELISAs_NP ._SENT Influenza_NN B/Yamagata_NP and_CC A/WSN_NP viruses_NNS ,_, as_RB well_RB as_IN recombinant_JJ WSN-BNA_NP ,_, WSN-BNA/A65_NP ,_, WSN-BNA/ACT_NP ,_, and_CC WSN-BNA/ACT-ATM_NP viruses_NNS ,_, were_VBD amplified_VBN in_IN MDCK_NP cells_NNS and_CC purified_VBN from_IN cell_NN culture_NN supernatants_NNS as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT purity_NN of_IN the_DT virus_NN preparations_NNS was_VBD confirmed_VBN by_IN SDS-PAGE_NP and_CC silver_NN staining_VBG (_( not_RB shown_VBN )_) ._SENT Equivalent_JJ amounts_NNS of_IN viruses_NNS were_VBD then_RB used_VBN in_IN the_DT ELISAs_NP ._SENT ELISA_NP plates_NNS were_VBD coated_VBN with_IN serial_JJ twofold_JJ dilutions_NNS of_IN recombinant_JJ and_CC parental_JJ viruses_NNS ,_, starting_VBG with_IN 0.25_CD mug_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT relative_JJ amounts_NNS of_IN the_DT influenza_NN B_NN virus_NN NA_NP proteins_NNS incorporated_VBN into_IN virions_NNS was_VBD measured_VBN as_IN intensity_NN of_IN alphaB_NP NA_NP antibody_NN binding_VBG to_TO virions_NNS ._SENT Both_DT recombinant_JJ WSN_NP viruses_NNS containing_VBG the_DT entire_JJ influenza_NN B_NN virus_NN NA_NP protein_NN (_( WSN-BNA_NP and_CC WSN-BNA/A65_NP viruses_NNS )_) showed_VBD an_DT approximately_RB twofold_JJ (_( 2.2-_CD and_CC 2.4-fold_JJ ,_, respectively)-higher_JJ NA_NP protein_NN content_NN compared_VBN to_TO wild-type_NN influenza_NN B/Yamagata_NP virus_NN ._SENT Results_NNS obtained_VBN from_IN the_DT measurement_NN of_IN the_DT NA_NP activity_NN of_IN equivalent_JJ amounts_NNS of_IN the_DT viruses_NNS by_IN using_VBG 2'-(4-methyl-umbelliferyl)-alpha-d-N-acetylneuraminic_JJ acid_NN (_( Mu-NANA_NP )_) as_IN a_DT substrate_NN support_VB this_DT finding_NN :_: the_DT NA_NP activity_NN of_IN WSN-BNA_NP virus_NN and_CC WSN-BNA/A65_NP virus_NN is_VBZ 1.8-_CD and_CC 2-fold_JJ ,_, respectively_RB ,_, greater_JJR than_IN that_DT of_IN B/Yamagata_NP virus_NN ._SENT However_RB ,_, in_IN chimeric_JJ WSN_NP viruses_NNS expressing_VBG BNA/ACT_NP or_CC BNA/ACT-ATM_NP ,_, the_DT levels_NNS of_IN NA_NP protein_NN incorporation_NN into_IN virions_NNS were_VBD 35_CD and_CC 14_CD %_NN ,_, respectively_RB ,_, of_IN that_IN of_IN wild-type_NN influenza_NN B_NN virus_NN ._SENT Again_RB ,_, the_DT content_NN of_IN the_DT NA_NP as_RB measured_VBD by_IN ELISA_NP corresponds_VBZ roughly_RB to_TO the_DT NA_NP activity_NN as_IN determined_VBN by_IN NA_NP assay_NN with_IN Mu-NANA_NP as_IN a_DT substrate_NN ,_, i.e._FW ,_, the_DT NA_NP activities_NNS of_IN WSN-BNA/ACT_NP virus_NN and_CC WSN-BNA/ACT-ATM_NP virus_NN were_VBD 27_CD and_CC 29_CD %_NN of_IN that_WDT found_VBD for_IN wild-type_NN influenza_NN B/Yamagata_NP virus_NN ._SENT Values_NNS obtained_VBN from_IN control_NN WSN-coated_JJ wells_NNS did_VBD not_RB differ_VB from_IN those_DT of_IN PBS-coated_JJ wells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Although_IN type_NN A_DT and_CC type_NN B_NN influenza_NN viruses_NNS are_VBP known_VBN to_TO cocirculate_VB in_IN humans_NNS ,_, the_DT formation_NN of_IN reassortant_JJ viruses_NNS has_VBZ never_RB been_VBN observed_VBN in_IN vivo_JJ or_CC ,_, for_IN that_DT matter_NN ,_, in_IN vitro_NN ._SENT Given_VBN that_IN the_DT HA_NP and_CC the_DT NA_NP of_IN influenza_NN A_NP and_CC B_NP viruses_NNS have_VBP similar_JJ functions_NNS ,_, we_PP explored_VBD the_DT possibility_NN that_IN the_DT type_NN B_NN glycoproteins_NNS could_MD functionally_RB replace_VB those_DT of_IN type_NN A_DT influenza_NN viruses_NNS ._SENT Here_RB we_PP report_VBP the_DT generation_NN of_IN infectious_JJ influenza_NN A_DT viruses_NNS expressing_VBG either_CC the_DT HA_NP or_CC the_DT NA_NP of_IN an_DT influenza_NN B_NN virus_NN ._SENT The_DT NA_NP protein_NN of_IN influenza_NN B/Lee/40_NP virus_NN had_VBD been_VBN shown_VBN earlier_RBR to_TO complement_VB the_DT influenza_NN A_DT virus_NN NA_NP in_IN an_DT NA-deficient_JJ type_NN A_DT virus_NN (_( NWS-Mvi_NP )_) and_CC to_TO be_VB packaged_VBN into_IN virions_NNS when_WRB overexpressed_VBN in_IN cells_NNS infected_VBN with_IN NWS-Mvi_NP ._SENT However_RB ,_, the_DT formation_NN of_IN an_DT infectious_JJ (_( nondefective_JJ )_) chimeric_JJ virus_NN expressing_VBG an_DT influenza_NN B_NN virus_NN glycoprotein_NN has_VBZ not_RB been_VBN demonstrated_VBN before_RB ._SENT We_PP employed_VBD a_DT plasmid-only_JJ transfection_NN system_NN for_IN the_DT generation_NN of_IN transfectant_JJ influenza_NN A_DT viruses_NNS expressing_VBG either_CC a_DT full-length_JJ influenza_NN B_NN virus_NN NA_NP ,_, chimeras_NNS between_IN type_NN A_DT and_CC type_NN B_NP NAs_NP ,_, or_CC a_DT chimeric_JJ HA_NP protein_NN ._SENT Both_CC recombinant_JJ viruses_NNS expressing_VBG the_DT full-length_JJ influenza_NN B_NN virus_NN NA_NP (_( WSN-BNA_NP and_CC WSN-BNA/A65_NP viruses_NNS )_) grow_VBP to_TO titers_NNS comparable_JJ to_TO that_DT of_IN the_DT isogenic_JJ influenza_NN A_DT virus_NN ._SENT Thus_RB ,_, influenza_NN B_NN virus_NN NAs_NP carrying_VBG the_DT NCRs_NN of_IN the_DT corresponding_JJ influenza_NN A_DT virus_NN segment_NN can_MD fully_RB replace_VB the_DT function_NN of_IN the_DT type_NN A_DT NA_NP in_IN viruses_NNS growing_VBG in_IN tissue_NN culture_NN ._SENT The_DT phenotype_NN of_IN these_DT viruses_NNS in_IN animal_JJ models_NNS has_VBZ not_RB been_VBN investigated_VBN ._SENT The_DT amount_NN of_IN NA_NP per_IN total_JJ viral_JJ protein_NN appears_VBZ to_TO be_VB twice_JJ that_IN found_VBN in_IN purified_VBN influenza_NN B_NN virus_NN preparations_NNS ,_, as_RB determined_VBN by_IN ELISAs_NP ._SENT However_RB ,_, it_PP is_VBZ not_RB clear_JJ whether_IN the_DT increased_VBN amount_NN of_IN NA_NP content_NN per_IN total_JJ micrograms_NNS of_IN protein_NN reflects_VBZ a_DT higher_JJR incorporation_NN rate_NN ,_, since_IN we_PP have_VBP not_RB determined_VBN the_DT amount_NN of_IN NA_NP expressed_VBD on_IN the_DT surface_NN of_IN infected_JJ cells_NNS ._SENT The_DT addition_NN of_IN 65_CD nt_NNS derived_VBN from_IN the_DT amino-terminal_JJ portion_NN of_IN the_DT influenza_NN A_DT virus_NN NA_NP ORF_NP to_TO the_DT 3_CD '_POS NCR_NP of_IN the_DT recombinant_JJ NA_NP in_IN BNA/A65_NP does_VBZ not_RB appear_VB to_TO change_VB the_DT phenotype_NN of_IN this_DT virus_NN ._SENT In_IN a_DT recently_RB published_VBN report_NN it_PP has_VBZ been_VBN postulated_VBN that_IN the_DT amino-terminal_JJ 21_CD nt_NNS of_IN the_DT NA_NP coding_VBG region_NN are_VBP critical_JJ for_IN the_DT packaging_NN of_IN the_DT NA_NP vRNA_NN segment_NN ._SENT It_PP is_VBZ likely_JJ that_IN a_DT similar_JJ packaging_NN signal_NN is_VBZ present_JJ in_IN the_DT ORF_NP of_IN the_DT influenza_NN B_NN virus_NN NA_NP ,_, since_IN the_DT WSN-BNA_NP virus_NN does_VBZ not_RB appear_VB to_TO have_VB a_DT lower_JJR growth_NN rate_NN ._SENT In_IN contrast_NN to_TO the_DT recombinant_JJ A/WSN_NP viruses_NNS expressing_VBG full-length_JJ type_NN B_NP NAs_NP ,_, the_DT rescued_VBN viruses_NNS containing_VBG chimeric_JJ NA_NP proteins_NNS (_( WSN-BNA/ACT_NP and_CC WSN-BNA/ACT-ATM_NP viruses_NNS )_) are_VBP compromised_VBN in_IN growth_NN in_IN MDCK_NP cells_NNS ._SENT They_PP grow_VBP to_TO an_DT at_IN least_JJS 1-log-lower_JJ titer_NN than_IN wild-type_NN influenza_NN A_DT virus_NN ._SENT The_DT ELISA_NP shows_VBZ that_IN these_DT purified_VBN viral_JJ preparations_NNS possess_VBP only_RB 35_CD and_CC 14_CD %_NN of_IN the_DT NA_NP protein_NN compared_VBN to_TO wild-type_NN virus_NN ._SENT The_DT reason_NN for_IN the_DT lower_JJR NA_NP content_NN in_IN WSN-BNA/ACT_NP and_CC WSN-BNA/ACT-ATM_NP viruses_NNS remains_VBZ unknown_JJ ._SENT One_CD possible_JJ explanation_NN could_MD be_VB that_IN the_DT protein_NN is_VBZ less_RBR stable_JJ due_RB to_TO replacement_NN of_IN the_DT cytoplasmic_JJ tail_NN or_CC of_IN the_DT cytoplasmic_JJ tail_NN plus_IN the_DT transmembrane_JJ region_NN of_IN the_DT influenza_NN B_NN virus_NN NA_NP (_( with_IN those_DT of_IN the_DT type_NN A_NP NA_NP )_) ._SENT Alternatively_RB ,_, packaging_NN of_IN the_DT chimeric_JJ NA_NP proteins_NNS could_MD be_VB decreased_VBN ,_, as_RB has_VBZ been_VBN shown_VBN with_IN transfectant_JJ influenza_NN A_DT viruses_NNS carrying_VBG point_NN mutations_NNS in_IN the_DT cytoplasmic_JJ tail_NN of_IN the_DT NA_NP ._SENT However_RB ,_, studies_NNS performed_VBD in_IN our_PP$ laboratory_NN with_IN NA/TAIL_JJ negative-strand_NN viruses_NNS showed_VBD that_DT deletion_NN of_IN the_DT entire_JJ cytoplasmic_JJ tail_NN did_VBD not_RB result_VB in_IN reduced_VBN packaging_NN of_IN the_DT NA_NP proteins_NNS into_IN virions_NNS ._SENT In_IN addition_NN to_TO the_DT four_CD recombinant_JJ viruses_NNS expressing_VBG all_DT or_CC part_NN of_IN the_DT influenza_NN B_NN virus_NN NA_NP protein_NN ,_, we_PP rescued_VBD an_DT influenza_NN A_DT virus_NN containing_VBG a_DT chimeric_JJ HA_NP protein_NN (_( WSN-BHA/ACT-ATM_NP virus_NN )_) ._SENT This_DT virus_NN did_VBD not_RB grow_VB to_TO high_JJ titers_NNS and_CC failed_VBD to_TO form_VB plaques_NNS in_IN MDCK_NP cells_NNS ,_, but_CC after_IN it_PP was_VBD passaged_VBN in_IN MDCK_NP cells_NNS we_PP obtained_VBD a_DT WSN-BHA/ACT-ATM_NP (_( P6_NP )_) virus_NN that_WDT forms_VBZ plaques_NNS and_CC grows_VBZ to_TO titers_NNS comparable_JJ to_TO that_DT of_IN wild-type_NN influenza_NN A_DT virus_NN ._SENT We_PP suggest_VBP that_IN the_DT occurrence_NN of_IN an_DT adaptive_JJ amino_NN acid_NN change_NN confers_VBZ the_DT increased_VBN growth_NN to_TO the_DT recombinant_JJ WSN-BHA/ACT-ATM_NP (_( P6_NP )_) virus_NN ._SENT Both_CC the_DT HA_NP and_CC the_DT NA_NP of_IN different_JJ influenza_NN A_DT viruses_NNS have_VBP been_VBN shown_VBN to_TO acquire_VB adaptive_JJ mutations_NNS as_IN a_DT result_NN of_IN altered_JJ HA-NA_NP combinations_NNS in_IN a_DT virus_NN ._SENT These_DT mutations_NNS led_VBN to_TO the_DT restoration_NN of_IN a_DT functional_JJ match_NN of_IN the_DT two_CD influenza_NN viral_JJ glycoproteins_NNS ._SENT It_PP was_VBD assumed_VBN that_IN mutations_NNS would_MD result_VB in_IN a_DT functional_JJ balance_NN between_IN the_DT two_CD opposing_VBG activities_NNS of_IN the_DT HA_NP and_CC NA_NP :_: one_CD being_VBG involved_VBN in_IN binding_VBG to_TO sialic_JJ acid_NN containing_VBG receptors_NNS and_CC the_DT other_JJ one_CD being_VBG involved_VBN in_IN the_DT removal_NN of_IN sialic_JJ acids_NNS from_IN virion_NN and_CC cell_NN surfaces_NNS ,_, respectively_RB ._SENT Our_PP$ analysis_NN of_IN the_DT passaged_VBN WSN-BHA/ACT-ATM_NP (_( P6_NP )_) virus_NN showed_VBD that_IN there_EX was_VBD no_DT consistent_JJ change_NN in_IN the_DT NA_NP ,_, but_CC all_DT HA_NP clones_NNS shared_VBD a_DT mutation_NN (_( H545Y_NP )_) ._SENT According_VBG to_TO the_DT structural_JJ organization_NN of_IN influenza_NN A_DT virus_NN HA_NP proteins_NNS proposed_VBN by_IN Nobusawa_NP et_FW al._FW ,_, the_DT amino_NN acid_NN at_IN position_NN 545_CD corresponds_VBZ to_TO the_DT carboxy-terminal_JJ amino_NN acid_NN of_IN the_DT influenza_NN A_DT virus_NN HA_NP ectodomain_NN ,_, and_CC the_DT transmembrane_NN domain_NN starts_VBZ at_IN position_NN 546_CD ._SENT Introduction_NN of_IN this_DT mutation_NN into_IN BHA/ACT-ATM_NP and_CC rescue_NN of_IN recombinant_JJ WSN-BHA/ACT-ATM_NP (_( H545Y_NP )_) showed_VBD that_IN this_DT amino_NN acid_NN change_NN could_MD fully_RB restore_VB the_DT growth_NN characteristics_NNS of_IN the_DT passaged_VBN virus_NN (_( P6_NP )_) ._SENT The_DT tyrosine_NN at_IN this_DT position_NN of_IN the_DT HA_NP protein_NN appears_VBZ to_TO play_VB an_DT important_JJ role_NN for_IN productive_JJ infection_NN of_IN recombinant_JJ influenza_NN A_DT virus_NN expressing_VBG this_DT chimeric_JJ HA_NP protein_NN in_IN tissue_NN culture_NN ._SENT One_CD possible_JJ explanation_NN may_MD be_VB that_IN the_DT tyrosine_NN close_NN to_TO the_DT transmembrane_NN region_NN may_MD be_VB needed_VBN for_IN maintaining_VBG the_DT stability_NN of_IN the_DT BHA/ACT-ATM_NP protein_NN ._SENT Alternatively_RB ,_, this_DT tyrosine_NN might_MD be_VB an_DT important_JJ functional_JJ component_NN of_IN the_DT transmembrane_JJ domain_NN of_IN the_DT wild-type_NN influenza_NN A_DT virus_NN HA_NP ._SENT An_DT additional_JJ chimeric_JJ construct_NN coding_VBG for_IN the_DT full-length_JJ type_NN B_NP HA_NP flanked_VBD by_IN the_DT influenza_NN A_DT virus_NN HA_NP NCRs_NP has_VBZ been_VBN generated_VBN ._SENT However_RB ,_, this_DT HA_NP segment_NN could_MD not_RB be_VB rescued_VBN into_IN the_DT A/WSN_NP virus_NN background_NN ._SENT Since_IN the_DT lack_NN of_IN reassortment_NN between_IN influenza_NN A_NP and_CC B_NP viruses_NNS is_VBZ not_RB due_JJ to_TO incompatibilities_NNS at_IN the_DT level_NN of_IN their_PP$ RNA_NP promoters_NNS or_CC of_IN their_PP$ NA_NP proteins_NNS (_( the_DT present_JJ study_NN )_) ,_, why_WRB have_VB A/B_NP NA_NP gene_NN reassortants_NNS never_RB been_VBN obtained_VBN ?_SENT One_CD possibility_NN is_VBZ that_IN the_DT expression_NN of_IN NB_NP from_IN the_DT wild-type_JJ B_NP virus_NN NA_NP gene_NN interferes_VBZ with_IN influenza_NN A_DT virus_NN replication_NN ._SENT Another_DT explanation_NN for_IN the_DT lack_NN of_IN reassortment_NN may_MD be_VB due_JJ to_TO incompatibilities_NNS at_IN the_DT level_NN of_IN the_DT ribonucleoprotein_NN complexes_NNS ._SENT For_IN instance_NN ,_, NP-RNA_NP complexes_NNS of_IN influenza_NN A_DT virus_NN are_VBP not_RB efficiently_RB replicated_VBN by_IN the_DT RNA-dependent_NP RNA_NP polymerase_NN of_IN influenza_NN B_NN virus_NN and_CC vice_JJ versa_RB ._SENT Thus_RB ,_, during_IN mixed_JJ influenza_NN A_NP and_CC B_NP virus_NN infections_NNS it_PP is_VBZ likely_JJ that_IN RNAs_NNS are_VBP only_RB replicated_VBN by_IN the_DT homologous_JJ viral_JJ RNA_NP polymerase_NN ._SENT A_DT heterologous_JJ ribonucleoprotein_NN complex_JJ containing_VBG P_NN (_( polymerase_NN )_) proteins_NNS and_CC NP_NN derived_VBN from_IN influenza_NN A_NP and_CC B_NP viruses_NNS would_MD be_VB inactive_JJ and_CC would_MD not_RB be_VB packaged_VBN into_IN viruses_NNS ._SENT In_IN any_DT case_NN ,_, our_PP$ results_NNS clearly_RB show_VBP that_DT lack_NN of_IN influenza_NN A/B_NP virus_NN reassortment_NN is_VBZ not_RB due_JJ to_TO an_DT incompatibility_NN at_IN the_DT level_NN of_IN their_PP$ NA_NP proteins_NNS or_CC at_IN that_DT of_IN the_DT HA_NP ectodomain_NN ._SENT NA_TO and_CC HA_NP genes_NNS used_VBD to_TO generate_VB recombinant_JJ influenza_NN A/WSN_NP viruses_NNS ._SENT NA_TO and_CC HA_NP genes_NNS used_VBD to_TO generate_VB recombinant_JJ influenza_NN A/WSN_NP viruses_NNS ._SENT (_( A_NP )_) Schematic_NP diagram_NN of_IN the_DT influenza_NN B/Yamagata/16/88_NP and_CC A/WSN/33_NP parental_JJ and_CC chimeric_JJ NA_NP genes_NNS showing_VBG the_DT ORFs_NNS of_IN the_DT NAs_NP ._SENT NCRs_NNS are_VBP indicated_VBN by_IN lines_NNS ._SENT CT_NP ,_, cytoplasmic_JJ tail_NN ;_: EC_NP ,_, ectodomain_NN ;_: TM_NP ,_, transmembrane_NN domain_NN ._SENT In_IN BNA/A65_NP and_CC BNA/ACT-ATM_NP the_DT NCRs_NN have_VBP been_VBN extended_VBN by_IN insertion_NN of_IN 65_CD nt_NNS into_IN the_DT 3_CD '_POS NCR_NP (_( nt_NN 20_CD to_TO 84_CD )_) and_CC insertion_NN of_IN 36_CD nt_NNS (_( nt_NN 1298_CD to_TO 1333_CD )_) into_IN the_DT 5_CD '_POS NCR_NP ,_, respectively_RB ._SENT Flu_NN B_NP wt_NP NA_NP ,_, influenza_NN B/Yamagata_NP wild-type_NN virus_NN NA_NP ;_: Flu_NP A_NP wt_NP NA_NP ,_, influenza_NN A/WSN_NP wild-type_NN virus_NN NA_NP ._SENT The_DT asterisk_NN in_IN Flu_NP B_NP wild-type_NP NA_NP indicates_VBZ the_DT position_NN of_IN the_DT start_NN codon_NN of_IN the_DT NB_NP protein_NN which_WDT is_VBZ upstream_RB of_IN that_DT of_IN the_DT NA_NP protein_NN ._SENT This_DT upstream_JJ sequence_NN coding_VBG for_IN the_DT amino_NN terminus_NN of_IN the_DT NB_NP protein_NN is_VBZ not_RB included_VBN in_IN the_DT chimeric_JJ constructs_NNS ._SENT (_( B_NP )_) Schematic_NP representation_NN of_IN the_DT influenza_NN B/Yamagata/16/88_NP and_CC A/WSN/33_NP virus_NN HA_NP and_CC the_DT chimeric_JJ BHA-ACT/ATM_NP segments_NNS ._SENT Flu_NN B_NP wt_NP HA_NP ,_, influenza_NN B/Yamagata_NP wild-type_NN virus_NN HA_NP ;_: Flu_NP A_NP wt_NP HA_NP ,_, influenza_NN A/WSN_NP wild-type_NN virus_NN HA_NP ._SENT The_DT ORFs_NNS are_VBP shown_VBN as_IN boxes_NNS ._SENT The_DT NCRs_NN are_VBP represented_VBN as_IN lines_NNS ._SENT CT_NP ,_, cytoplasmic_JJ tail_NN ;_: EC_NP ,_, ectodomain_NN ;_: TM_NP ,_, transmembrane_NN domain_NN ._SENT For_IN details_NNS ,_, see_VBP Materials_NPS and_CC Methods_NP ._SENT Immunofluorescence_NN analysis_NN of_IN MDCK_NP cells_NNS infected_VBN with_IN recombinant_JJ viruses_NNS ._SENT Immunofluorescence_NN analysis_NN of_IN MDCK_NP cells_NNS infected_VBN with_IN recombinant_JJ viruses_NNS ._SENT (_( A_NP )_) Recombinant_NP influenza_NN A_DT viruses_NNS expressing_VBG recombinant_JJ influenza_NN B_NN virus_NN NAs_NP ._SENT Subpanels_NNS :_: A_DT and_CC D_NP ,_, wild-type_NN influenza_NN B/Yamagata_NP virus_NN ,_, B_NP and_CC C_NP ,_, wild-type_NN influenza_NN A/WSN_NP virus_NN ;_: E_NP and_CC F_NP ,_, WSN-BNA_NP virus_NN ;_: G_NP and_CC H_NP ,_, WSN-BNA/A65_NP virus_NN ;_: I_PP and_CC J_NP ,_, WSN-BNA/ACT_NP virus_NN ;_: K_NP and_CC L_NP ,_, WSN-BNA/ACT-ATM_NP virus_NN ._SENT (_( B_NP )_) Recombinant_NP influenza_NN A_DT virus_NN expressing_VBG the_DT HA_NP ectodomain_NN of_IN influenza_NN B_NN virus_NN ._SENT Subpanels_NNS :_: A_DT and_CC B_NP ,_, mock_JJ infection_NN ;_: C_NP and_CC D_NP WSN-BHA/ACT-ATM_NP virus_NN ._SENT alpha_NN Flu_NP 